Jun 16, 2025
38:1
For every share held, investors received 38. The price per share adjusted from $2280.00 to $60.00.
The split itself did not change the total investment value.
Regencell Bioscience Holdings Limited (RGC) trades on the NASDAQ Capital Market in the Drug Manufacturers - Specialty & Generic industry.
Regencell Bioscience Holdings Limited company overviewThe latest split shown was on June 16, 2025. It was a 38-for-1 forward split, so shareholders received 38 shares for every share they held.
This history records one forward split, on June 16, 2025.
Already premium?